{ "schemaVersion": 1, "organisationId": "O-79694e53083f4d2cbdba286e5be3086d", "slug": "altria-group", "name": "ALTRIA GROUP, INC.", "updatedAt": "2026-10-03T22:14:55.997511Z", "sections": [ { "type": "OVERVIEW", "text": "Altria Group, Inc. is a U.S.-focused tobacco and nicotine company whose businesses make and sell cigarettes, cigars, smokeless tobacco, oral nicotine pouches and e-vapor products. Its principal brands include Marlboro, Copenhagen, Skoal, Black & Mild, on! and NJOY; its main reportable segments are Smokeable Products, Oral Tobacco Products and E-Vapor Products. [P8100601][P37445008][P88098745][https://www.sec.gov/Archives/edgar/data/764180/000076418026000052/annualreportaltriagroup25a.pdf]\n\nAltria’s stated vision is “Moving Beyond Smoking,” with an emphasis on a smoke-free future for adult smokers; its broader purpose is “Elevating the Everyday – one moment at a time.” Operations and sales are primarily in the United States, with products sold through more than 300,000 retailers across the 50 states. For FY2025, consolidated net revenue was $23.279 billion; the company’s fact sheet reports approximately 5,900 employees. [P8100601][P37445008][https://www.sec.gov/Archives/edgar/data/764180/000076418026000052/annualreportaltriagroup25a.pdf][https://www.altria.com/about-altria/our-vision-and-cultural-aspiration][https://www.altria.com/about-altria/At_A_Glance/corporate-fact-sheet][T10364942]\n[P8100601][P37445008][P88098745][T10364942][https://www.sec.gov/Archives/edgar/data/764180/000076418026000052/annualreportaltriagroup25a.pdf][https://www.altria.com/about-altria/our-vision-and-cultural-aspiration][https://www.altria.com/about-altria/At_A_Glance/corporate-fact-sheet]", "updatedAt": "2026-10-03T22:14:55.997511Z" }, { "type": "PRODUCTS", "text": "Altria’s smokeable products include cigarettes sold by Philip Morris USA (PM USA), led by Marlboro, and machine-made large cigars sold by John Middleton, principally under the Black & Mild brand. In FY2025, U.S. cigarette shipments were 61.8 billion units, down 10.0% year over year, while Middleton cigar shipments were approximately 1.8 billion units, up 1.8%. [P3648475][https://www.altria.com/About-Altria/our-companies/philipmorrisusa] [P100347809]\n\nIts oral products include moist smokeless tobacco (MST)—including Copenhagen, Skoal and Red Seal—and Helix’s on! nicotine pouches. FY2025 oral-segment shipments were 732.4 million units, down 5.5%. The on! range includes Wintergreen, Mint, Cinnamon, Coffee, Citrus, Berry and Original Tobacco flavors, with listed nicotine strengths of 2, 4, 6, 8, 9 and 12 mg. [P117735340][P25312945][https://www.onnicotine.com/]\n\nAltria’s e-vapor portfolio includes NJOY tobacco- and menthol-flavored products; NJOY ACE is its principal product, and the company has disclosed regulatory restrictions prohibiting its U.S. importation and sale. Altria has also described a planned heated-tobacco platform with JTI involving Ploom devices and Marlboro HTS consumables; as of February 25, 2026, no products from the joint venture were available in the U.S. marketplace. [P72237740][P96965492]\n\nFor FY2025, reported net revenues imply that smokeable products represented approximately 88.0% and oral tobacco approximately 12.0% of consolidated net revenues; these are segment-level proportions, not sales shares for individual brands or products. The report does not provide product-level revenue figures. [T9141890]\n[P3648475][P100347809][P117735340][P25312945][P72237740][P96965492][T9141890][T9141890][T9141890][T9141890][T9141890][https://www.altria.com/About-Altria/our-companies/philipmorrisusa][https://www.onnicotine.com/]", "updatedAt": "2026-10-03T22:14:55.997511Z" }, { "type": "GEOGRAPHY", "text": "Altria Group, Inc. operates primarily in the United States and derives substantially all of its revenue from domestic customers; its 2025 Form 10-K does not provide a country-by-country revenue breakdown or a precise percentage attributable to U.S. sales. The company identifies limited distribution of on! PLUS in Sweden and the United Kingdom, but does not report these markets as a separate share of group revenue. [P37445008][P109873179][https://www.altria.com/about-altria/our-companies/helix-innovations]\n\nAltria’s principal executive offices are in Richmond, Virginia. Its disclosed facilities include a cigarette manufacturing plant and research and technology center in Richmond, and major oral-tobacco manufacturing or processing facilities in Nashville, Tennessee, and Hopkinsville, Kentucky. The company reports approximately 5,900 employees, 97% of whom reside in the United States; this is a residence figure, not a work-location breakdown. [P23420657][P105737288][P57216281][P27951620][https://www.altria.com/about-altria/At_A_Glance/corporate-fact-sheet]\n[P37445008][P109873179][P23420657][P105737288][P57216281][P27951620][https://www.altria.com/about-altria/our-companies/helix-innovations][https://www.altria.com/about-altria/At_A_Glance/corporate-fact-sheet]", "updatedAt": "2026-10-03T22:14:55.997511Z" }, { "type": "SEGMENTS", "text": "Altria’s 2025 reportable segments are Smokeable products, Oral tobacco products, and E-vapor products. E-vapor became a separate reportable segment in 2025, and comparative segment information was recast. [P89841231][P41607255]\n\nSmokeable products covers cigarettes and machine-made large cigars, including Marlboro and Black & Mild. [P3648475][P100347809] In 2025 it generated $20.485 billion in net revenue, approximately 88.0% of consolidated net revenue, and $10.984 billion in operating companies income (OCI). [T9141890] Oral tobacco products covers smokeless tobacco and oral nicotine pouch products, including Copenhagen, Skoal, Red Seal, and on! [P117735340][P72237740] It generated $2.802 billion in net revenue, approximately 12.0% of the consolidated total, and $1.828 billion in OCI. [T9141890] E-vapor products generated negative net revenue of $13 million (approximately −0.1% of the consolidated total) and negative OCI of $2.297 billion. [T9141890]\n\nThe “all other” category is not a reportable segment; it includes Horizon, Helix International, and other activities, primarily research and development for new product platforms and technologies. [P50335994] It contributed $5 million in net revenue in 2025, approximately 0.0% of the consolidated total. [T9141890] Revenue percentages are calculated from reported segment net revenues divided by consolidated net revenue of $23.279 billion. [T9141890]\n[P89841231][P41607255][P3648475][P100347809][T9141890][P117735340][P72237740][P50335994]", "updatedAt": "2026-10-03T22:14:55.997511Z" }, { "type": "HISTORY", "text": "Philip Morris’s predecessor began as a tobacco and ready-made-cigarette shop in London in 1847; Philip Morris & Co., Ltd. was incorporated in New York in 1902. Marlboro was repositioned as a cigarette brand in 1924, and Philip Morris selected Richmond, Virginia, as its manufacturing hub in 1929.[https://www.altria.com/About-Altria/our-companies/philipmorrisusa][https://www.altria.com/About-Altria/Our-Heritage]\n\nThe company expanded beyond tobacco with its 1970 acquisition of Miller Brewing Company, followed by the formation of Philip Morris Companies as a publicly held parent in 1985 and the acquisitions of General Foods and Kraft in 1985 and 1988, respectively.[https://www.altria.com/About-Altria/Our-Heritage][https://www.britannica.com/money/Altria-Group] In 1998, Philip Morris and other major cigarette manufacturers signed the Master Settlement Agreement with U.S. states and territories.[https://www.philipmorrisusa.com/products/tobacco-settlement-agreements]\n\nPhilip Morris Companies adopted the name Altria Group, Inc. in 2003. Altria spun off Kraft Foods in 2007 and Philip Morris International in 2008, and acquired cigar and pipe-tobacco maker John Middleton in 2007 and UST Inc. in 2009.[https://www.altria.com/About-Altria/Our-Heritage][https://www.sec.gov/Archives/edgar/data/764180/000119312507070747/dex991.htm][https://www.altria.com/About-Altria/our-companies/johnmiddleton][https://investor.altria.com/frequently-asked-questions/]\n\nIn 2018 Altria made a minority investment in JUUL, followed by a 45% stake in Cronos Group in 2019. Billy Gifford became CEO in April 2020; Altria completed its acquisition of NJOY Holdings in 2023 and assigned its exclusive U.S. IQOS commercialization rights to Philip Morris International in 2024.[https://investor.altria.com/press-releases/news-details/2020/Altria-Announces-Conversion-of-Its-Non-Voting-Shares-in-JUUL-Does-Not-Intend-to-Exercise-Governance-Rights-Pending-FTC-Litigation-Outcome/default.aspx][https://www.altria.com/about-altria/our-companies/investments][https://investor.altria.com/press-releases/news-details/2020/Altria-Announces-Leadership-and-Governance-Changes/default.aspx][https://investor.altria.com/press-releases/news-details/2023/Altria-Completes-Acquisition-of-NJOY-Holdings-Inc.-Updates-2023-Full-Year-Earnings-Guidance/default.aspx][P14580644][P5991202]\n[P14580644][P5991202][https://www.altria.com/About-Altria/our-companies/philipmorrisusa][https://www.altria.com/About-Altria/Our-Heritage][https://www.britannica.com/money/Altria-Group][https://www.philipmorrisusa.com/products/tobacco-settlement-agreements][https://www.sec.gov/Archives/edgar/data/764180/000119312507070747/dex991.htm][https://www.altria.com/About-Altria/our-companies/johnmiddleton][https://investor.altria.com/frequently-asked-questions/][https://investor.altria.com/press-releases/news-details/2020/Altria-Announces-Conversion-of-Its-Non-Voting-Shares-in-JUUL-Does-Not-Intend-to-Exercise-Governance-Rights-Pending-FTC-Litigation-Outcome/default.aspx][https://www.altria.com/about-altria/our-companies/investments][https://investor.altria.com/press-releases/news-details/2020/Altria-Announces-Leadership-and-Governance-Changes/default.aspx][https://investor.altria.com/press-releases/news-details/2023/Altria-Completes-Acquisition-of-NJOY-Holdings-Inc.-Updates-2023-Full-Year-Earnings-Guidance/default.aspx]", "updatedAt": "2026-10-03T22:14:55.997511Z" } ], "sources": [ { "id": "P8100601", "href": "https://app.finbar.com/go?id=P8100601", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "P37445008", "href": "https://app.finbar.com/go?id=P37445008", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "P88098745", "href": "https://app.finbar.com/go?id=P88098745", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "https://www.sec.gov/Archives/edgar/data/764180/000076418026000052/annualreportaltriagroup25a.pdf", "href": "https://www.sec.gov/Archives/edgar/data/764180/000076418026000052/annualreportaltriagroup25a.pdf", "label": "www.sec.gov" }, { "id": "https://www.altria.com/about-altria/our-vision-and-cultural-aspiration", "href": "https://www.altria.com/about-altria/our-vision-and-cultural-aspiration", "label": "www.altria.com" }, { "id": "https://www.altria.com/about-altria/At_A_Glance/corporate-fact-sheet", "href": "https://www.altria.com/about-altria/At_A_Glance/corporate-fact-sheet", "label": "www.altria.com" }, { "id": "T10364942", "href": "https://app.finbar.com/go?id=T10364942", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "P3648475", "href": "https://app.finbar.com/go?id=P3648475", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "https://www.altria.com/About-Altria/our-companies/philipmorrisusa", "href": "https://www.altria.com/About-Altria/our-companies/philipmorrisusa", "label": "www.altria.com" }, { "id": "P100347809", "href": "https://app.finbar.com/go?id=P100347809", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "P117735340", "href": "https://app.finbar.com/go?id=P117735340", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "P25312945", "href": "https://app.finbar.com/go?id=P25312945", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "https://www.onnicotine.com/", "href": "https://www.onnicotine.com/", "label": "www.onnicotine.com" }, { "id": "P72237740", "href": "https://app.finbar.com/go?id=P72237740", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "P96965492", "href": "https://app.finbar.com/go?id=P96965492", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "T9141890", "href": "https://app.finbar.com/go?id=T9141890", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "P109873179", "href": "https://app.finbar.com/go?id=P109873179", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "https://www.altria.com/about-altria/our-companies/helix-innovations", "href": "https://www.altria.com/about-altria/our-companies/helix-innovations", "label": "www.altria.com" }, { "id": "P23420657", "href": "https://app.finbar.com/go?id=P23420657", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "P105737288", "href": "https://app.finbar.com/go?id=P105737288", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "P57216281", "href": "https://app.finbar.com/go?id=P57216281", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "P27951620", "href": "https://app.finbar.com/go?id=P27951620", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "P89841231", "href": "https://app.finbar.com/go?id=P89841231", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "P41607255", "href": "https://app.finbar.com/go?id=P41607255", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "P50335994", "href": "https://app.finbar.com/go?id=P50335994", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "https://www.altria.com/About-Altria/Our-Heritage", "href": "https://www.altria.com/About-Altria/Our-Heritage", "label": "www.altria.com" }, { "id": "https://www.britannica.com/money/Altria-Group", "href": "https://www.britannica.com/money/Altria-Group", "label": "www.britannica.com" }, { "id": "https://www.philipmorrisusa.com/products/tobacco-settlement-agreements", "href": "https://www.philipmorrisusa.com/products/tobacco-settlement-agreements", "label": "www.philipmorrisusa.com" }, { "id": "https://www.sec.gov/Archives/edgar/data/764180/000119312507070747/dex991.htm", "href": "https://www.sec.gov/Archives/edgar/data/764180/000119312507070747/dex991.htm", "label": "www.sec.gov" }, { "id": "https://www.altria.com/About-Altria/our-companies/johnmiddleton", "href": "https://www.altria.com/About-Altria/our-companies/johnmiddleton", "label": "www.altria.com" }, { "id": "https://investor.altria.com/frequently-asked-questions/", "href": "https://investor.altria.com/frequently-asked-questions/", "label": "investor.altria.com" }, { "id": "https://investor.altria.com/press-releases/news-details/2020/Altria-Announces-Conversion-of-Its-Non-Voting-Shares-in-JUUL-Does-Not-Intend-to-Exercise-Governance-Rights-Pending-FTC-Litigation-Outcome/default.aspx", "href": "https://investor.altria.com/press-releases/news-details/2020/Altria-Announces-Conversion-of-Its-Non-Voting-Shares-in-JUUL-Does-Not-Intend-to-Exercise-Governance-Rights-Pending-FTC-Litigation-Outcome/default.aspx", "label": "investor.altria.com" }, { "id": "https://www.altria.com/about-altria/our-companies/investments", "href": "https://www.altria.com/about-altria/our-companies/investments", "label": "www.altria.com" }, { "id": "https://investor.altria.com/press-releases/news-details/2020/Altria-Announces-Leadership-and-Governance-Changes/default.aspx", "href": "https://investor.altria.com/press-releases/news-details/2020/Altria-Announces-Leadership-and-Governance-Changes/default.aspx", "label": "investor.altria.com" }, { "id": "https://investor.altria.com/press-releases/news-details/2023/Altria-Completes-Acquisition-of-NJOY-Holdings-Inc.-Updates-2023-Full-Year-Earnings-Guidance/default.aspx", "href": "https://investor.altria.com/press-releases/news-details/2023/Altria-Completes-Acquisition-of-NJOY-Holdings-Inc.-Updates-2023-Full-Year-Earnings-Guidance/default.aspx", "label": "investor.altria.com" }, { "id": "P14580644", "href": "https://app.finbar.com/go?id=P14580644", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" }, { "id": "P5991202", "href": "https://app.finbar.com/go?id=P5991202", "label": "ALTRIA GROUP, INC. — Full financial report (2025 Y)", "documentId": "D-a4a0e40657a64c74bd460d676f3aaf1f" } ] }